ralimetinib small molecule experimental cancer drug development eli lilly although originally thought mitogenactivated protein kinase mapk since reported acts instead epidermal growth factor receptor egfr phase ii trial treatment ovarian cancer httpsenwikipediaorgwikiralimetinib